Celularity Inc current report, 11 July 2019

SEC Form 8-K Summary

Business Context and Reporting Period

The filing is a Current Report on Form 8-K filed by GX Acquisition Corp., not Celularity Inc., with an event date of July 11, 2019 and a filing date of July 12, 2019. The report concerns the planned separation and separate trading of the company’s publicly issued units, Class A common stock, and warrants.

Key Financial and Capital Markets Information

  • GX Acquisition Corp. completed its initial public offering on May 23, 2019.
  • The IPO comprised 28,750,000 units, including 3,750,000 units issued upon the underwriter’s full exercise of its over-allotment option.
  • Each unit consisted of one share of Class A common stock and one-half of one redeemable warrant.
  • Each whole warrant entitles the holder to purchase one Class A common share at $11.50 per share.
  • The units were sold at $10.00 each, generating gross IPO proceeds of $287.5 million.
  • The filing provides no revenue, earnings, cash flow, margin, debt, or liquidity metrics for the reporting period.

Material Changes Versus the Prior Comparable Period

No operating or financial-period comparison is provided. The material event is that, beginning July 15, 2019, holders may elect to separate the units into Class A common stock and warrants.

  • Units that remain intact continue trading on Nasdaq under GXGXU.
  • Separated Class A common stock trades under GXGX.
  • Separated warrants trade under GXGXW.
  • No fractional warrants will be issued; only whole warrants will trade.

Guidance, Outlook, Risks, and Unusual Items

The filing provides no financial guidance or operating outlook. Investors must instruct their brokers to contact Continental Stock Transfer & Trust Company, the transfer agent, to separate units. The filing does not describe additional contingencies, debt arrangements, or unusual accounting items.

Important Facts to Verify

  • Verify that the intended issuer is GX Acquisition Corp.; the provided request metadata identifies Celularity Inc., which does not match the registrant named in the filing.
  • Confirm the July 15, 2019 commencement date for separate trading.
  • Confirm the applicable ticker symbols: GXGXU, GXGX, and GXGXW.
  • Review the warrant terms, including the $11.50 exercise price and whole-warrant requirement.
  • Confirm the reported IPO size and gross proceeds of 28.75 million units and $287.5 million, respectively.